General Statement of Disclosure:
CONSULTING FEES/HONORARIA: XyloCor(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Biocardia(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elsevier (SIGNIFICANT)
The ACC will perform system updates on Oct. 15 from 8-11 p.m. ET. During this time, online purchases and payment processing will be unavailable. Thank you for your understanding.
CONSULTING FEES/HONORARIA: XyloCor(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Biocardia(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elsevier (SIGNIFICANT)